Education
About Us
Working with TipRanks
Follow Us
Modalis Therapeutics Corporation (JP:4883)
:4883
4883 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥62.00 - ¥203.00
Previous CloseN/A
Volume5.80M
Average Volume (3M)1.81M
Market Cap
¥6.62B
Enterprise Value¥3.50B
Total Cash (Recent Filing)¥3.58B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.20
Next Earnings
May 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-30.92
Shares Outstanding73,548,996
10 Day Avg. Volume1,068,100
30 Day Avg. Volume1,811,116
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Modalis Therapeutics Corporation News
PremiumCompany Announcements
Modalis Therapeutics Issues Stock Options to Boost Performance
PremiumCompany Announcements
Modalis Therapeutics Unveils FY2025 Business Plans with High Growth Potential
PremiumCompany Announcements
Modalis Therapeutics Announces Change in Audit Firm
PremiumCompany Announcements
Modalis Therapeutics Restructures Capital to Address Earnings Deficit
PremiumCompany Announcements
Modalis Therapeutics Reports Reduced Losses Due to Lower R&D Expenses
PremiumCompany Announcements
Modalis Therapeutics Reports Foreign Exchange Gains
PremiumCompany Announcements
Modalis Therapeutics Reports Reduced Losses in 2024 Financial Results---
4883 FAQ
What was Modalis Therapeutics Corporation’s price range in the past 12 months?
Modalis Therapeutics Corporation lowest stock price was ¥62.00 and its highest was ¥203.00 in the past 12 months.
What is Modalis Therapeutics Corporation’s market cap?
Modalis Therapeutics Corporation’s market cap is ¥6.62B.
When is Modalis Therapeutics Corporation’s upcoming earnings report date?
Modalis Therapeutics Corporation’s upcoming earnings report date is May 13, 2025 which is in 42 days.
How were Modalis Therapeutics Corporation’s earnings last quarter?
Modalis Therapeutics Corporation released its earnings results on Feb 13, 2025. The company reported -¥1.36 earnings per share for the quarter, missing the consensus estimate of N/A by -¥1.36.
Is Modalis Therapeutics Corporation overvalued?
According to Wall Street analysts Modalis Therapeutics Corporation’s price is currently Overvalued.
Does Modalis Therapeutics Corporation pay dividends?
Modalis Therapeutics Corporation does not currently pay dividends.
What is Modalis Therapeutics Corporation’s EPS estimate?
Modalis Therapeutics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modalis Therapeutics Corporation have?
Modalis Therapeutics Corporation has 73,548,996 shares outstanding.
What happened to Modalis Therapeutics Corporation’s price movement after its last earnings report?
Modalis Therapeutics Corporation reported an EPS of -¥1.36 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.98%.
Which hedge fund is a major shareholder of Modalis Therapeutics Corporation?
Currently, no hedge funds are holding shares in JP:4883
---
Company Description
Modalis Therapeutics Corporation
Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.
---
Technical Analysis
SanBio Co
―
NanoCarrier Co., Ltd.
―
RaQualia Pharma Inc.
―
Chiome Bioscience Inc.
―
Kidswell Bio Corporation
―
---